ARTCLINE appoints Dirk Hessel as Managing Director and Prepares the Market Entry for Innovative Septic Shock Treatment
First Patients enrolled in EU randomized Trial of ARTCLINEs Immune-cell Therapy System for treatment of septic shock
ARTCLINE receives 4 million euros and starts clinical trial with novel immune cell therapy for septic shock patients
The Federal Ministry for Economic Affairs and Energy promotes ARTCLINE’s extracorporeal immune cell therapy
European patent granted to ARTCLINE for a “LEUKOCYTE PREPARATION” and the respective production method